- Home
- BBIO vs GME Comparison
BBIO vs GME Comparison
Compare BBIO & GME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- GME
- Stock Information
- Founded
- BBIO 2015
- GME 1996
- Country
- BBIO United States
- GME United States
- Employees
- BBIO N/A
- GME N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- GME Electronics Distribution
- Sector
- BBIO Health Care
- GME Consumer Discretionary
- Exchange
- BBIO Nasdaq
- GME Nasdaq
- Market Cap
- BBIO 12.5B
- GME 11.8B
- IPO Year
- BBIO 2019
- GME 2002
- Fundamental
- Price
- BBIO $71.90
- GME $21.79
- Analyst Decision
- BBIO Strong Buy
- GME Sell
- Analyst Count
- BBIO 19
- GME 1
- Target Price
- BBIO $74.79
- GME $13.50
- AVG Volume (30 Days)
- BBIO 2.4M
- GME 5.2M
- Earning Date
- BBIO 10-29-2025
- GME 12-09-2025
- Dividend Yield
- BBIO N/A
- GME N/A
- EPS Growth
- BBIO N/A
- GME 481.76
- EPS
- BBIO N/A
- GME 0.76
- Revenue
- BBIO $353,780,000.00
- GME $3,847,500,000.00
- Revenue This Year
- BBIO $123.32
- GME $9.86
- Revenue Next Year
- BBIO $73.46
- GME $2.83
- P/E Ratio
- BBIO N/A
- GME $28.51
- Revenue Growth
- BBIO 62.46
- GME N/A
- 52 Week Low
- BBIO $25.34
- GME $19.93
- 52 Week High
- BBIO $72.26
- GME $35.81
- Technical
- Relative Strength Index (RSI)
- BBIO 71.58
- GME 51.44
- Support Level
- BBIO $64.41
- GME $19.94
- Resistance Level
- BBIO $67.71
- GME $20.69
- Average True Range (ATR)
- BBIO 2.80
- GME 0.59
- MACD
- BBIO 0.35
- GME 0.14
- Stochastic Oscillator
- BBIO 95.73
- GME 99.21
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About GME GameStop Corporation
GameStop Corp is a U.S. multichannel video game, consumer electronics, and services retailer. The company operates across Europe, Canada, Australia, and the United States. The company sells new and second-hand video game hardware, physical and digital video game software, and video game accessories, mainly through GameStop, EB Games, and Micromania stores and international e-commerce sites. The majority of sales are from the United States. The company categorizes its products in three categories: Hardware and accessories, Software, and Collectibles. The company generates the majority of its revenue from the sale of Hardware and accessories products.